Full Length Research Paper
References
|
Anderson SL, Griend JP (2014). Quetiapine for insomnia: A review of the literature. American Journal of Health-System Pharmacy 71(5):394-402. |
|
|
Bashawri H (2013). Sleepless in Makkah City, Saudi Arabia: Prevalence and Risk Factors of Insomnia and the Variations in Sleep Quality among Visitors of Primary Health Care Centers. MPH. Emory University. |
|
|
Botts SR, Raskind J (1999). Gabapentin and lamotrigine in bipolar disorder. American Journal of Health-System Pharmacy 56(19):1939-1944. |
|
|
Calabrese JR, Bowden CL, Sachs GS, Ascher JA, Monaghan E, Rudd GD (1999). A Double-Blind Placebo-Controlled Study of Lamotrigine Monotherapy in Outpatients With Bipolar I Depression. The Journal of Clinical Psychiatry 60(2):79-88. |
|
|
Eguale T, Buckeridge DL, Verma A, Winslade NE, Benedetti A, Hanley JA, Tamblyn R (2016). Association of Off-label Drug Use and Adverse Drug Events in an Adult Population. JAMA Internal Medicine 176(1):55. |
|
|
Eguale T, Buckeridge DL, Winslade NE, Benedetti A, Hanley JA, Tamblyn R (2012). Drug, Patient, and Physician Characteristics Associated With Off-label Prescribing in Primary Care. Archives of Internal Medicine 172(10): |
|
|
Franco V, Canevini MP, Capovilla G, Sarro GD, Galimberti CA, Gatti G, Perucca E (2014). Off-Label Prescribing of Antiepileptic Drugs in Pharmacoresistant Epilepsy: A Cross-Sectional Drug Utilization Study of Tertiary Care Centers in Italy. CNS Drugs 28(10):939-949. |
|
|
Fukada C, Kohler JC, Boon H, Austin Z, Krahn M (2012). Prescribing Gabapentin off Label: Perspectives from Psychiatry, Pain and Neurology Specialists. Canadian Pharmacists Journal / Revue Des Pharmaciens Du Canada 145(6). |
|
|
Kamath L (2017). Cost variation analysis study of oral anti-depressant drugs available in India. International Journal of Basic and Clinical Pharmacology 6(4):973. |
|
|
Maher AR, Maglione M, Bagley S, Suttorp M, Hu J, Ewing B, Shekelle PG (2011). Efficacy and Comparative Effectiveness of Atypical Antipsychotic Medications for Off-Label Uses in Adults. Jama 306(12):1359. |
|
|
Mercier A, Auger-Aubin I, Lebeau J, Schuers M, Boulet P, Hermil J, Peremans L (2013). Evidence of prescription of antidepressants for non-psychiatric conditions in primary care: An analysis of guidelines and systematic reviews. BMC Family Practice 14(1). |
|
|
Onyenwenyi AJ (2008). Off-label prescribing of anticonvulsant drugs. (Order No. 3381471, University of Florida). ProQuest Dissertations and Theses, p. 184. |
|
|
Park Susie H, Pharm D, BCPP, FCSHP (2013). Off-label use of atypical antipsychotics: Lack of evidence for their use in primary insomnia. Formulary 48(11):361-362,365-368,370-376. |
|
|
Rahajeng B, Ikawati Z, Andayani TM, Dwiprahasto I (2018). A Retrospective Study: The Off-Label Use Of Anticonvulsants At A Private Hospital In Indonesia. International Journal of Pharmacy and Pharmaceutical Sciences 10(5):119. |
|
|
Sartori SB, Singewald N (2019). Novel pharmacological targets in drug development for the treatment of anxiety and anxiety-related disorders. Pharmacology and Therapeutics 107402. |
|
|
Shrestha R, Prajapati S (2019). Assessment of prescription pattern and prescription error in outpatient Department at Tertiary Care District Hospital, Central Nepal. Journal of Pharmaceutical Policy and Practice 12(1):16. |
|
|
Varghese D, Carroll N (2015). Resource Utilization and costs associated with off-label use of atypical Antipsychotics in a Community-Dwelling Adult Population: Findings from the Medical Expenditure Survey. Value in Health 18(3): |
|
|
Walton SM, Schumock GT, Lee K, Alexander GC, Meltzer D, Stafford RS (2008). Prioritizing Future Research on Off-Label Prescribing: Results of a Quantitative Evaluation. Pharmacotherapy. The Journal of Human Pharmacology and Drug Therapy 28(12):1443-1452. |
|
|
Wittich CM, Burkle CM, Lanier WL. (2012). Ten common questions (and theiranswers) about off-label drug use. Mayo Clinic Proceedings. 356:982-90. |
|
|
Wong J, Motulsky A, Abrahamowicz M, Eguale T, Buckeridge DL, Tamblyn R (2017). Off-label indications for antidepressants in primary care: Descriptive study of prescriptions from an indication based electronic prescribing system. BMJ 356, j603. |
|
|
Wong J, Motulsky A, Eguale T, Buckeridge DL, Abrahamowicz M, Tamblyn R (2016). Treatment Indications for Antidepressants Prescribed in Primary Care in Quebec, Canada, 2006-2015. Jama 315(20):2230. |
|
Copyright © 2024 Author(s) retain the copyright of this article.
This article is published under the terms of the Creative Commons Attribution License 4.0
